向CD161抑制受体增强了NK细胞介导的状纤维细胞功能在类风湿性关节炎中的变化
Junqin Lu1, Jiale Song2, Hongwei Yu1
1Department of Orthopedics, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu 222000, China.
International immunopharmacology
|September 13, 2025
概括
CD161,NK细胞上的受体,作为类风湿性关节炎 (RA) 的生物标志物显示出希望. 向NK细胞中的CD161可以减少关节炎症,为RA提供新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 分子生物学分子生物学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,可靠的生物标志物有限.
- CD161作为RA病变发生的抑制受体的作用及其对治疗反应的预测潜力需要进一步澄清.
研究的目的:
- 为了研究RA中CD161的表达.
- 探索CD161在RA病变发生过程中的机制性作用.
- 评估向RA中的CD161的治疗潜力.
主要方法:
- 结合RNA测序 (RNA-seq),单细胞RNA测序 (scRNA-seq) 和临床样本分析.
- 使用了原诱导性关节炎 (CIA) 模型与NK细胞注射.
- 用IFN-γ,全基因组测序和共同培养试验进行了纤维细胞样同胞细胞 (FLS) 的体外刺激.
主要成果:
- CD161在RA患者的同胞NK细胞中过度表达,与NK细胞衍生IFN-γ负相关.
- 在关节内注射NK细胞,调节CD161表达,部分缓解了CIA突炎.
- 发现CD161通过IFN-γ和PI3K-AKT通路抑制FLS的瘤性质.
结论:
- CD161被认为是类风湿性关节炎的潜在生物标志物.
- 向NK细胞中的CD161通过减轻RA中的突发性炎症来证明治疗潜力.
相关概念视频
T Cell Types and Functions
2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
499
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
499
The JAK-STAT Signaling Pathway
12.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.1K
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K


